Vyvanse is the brand name for lisdexamfetamine, a long acting Schedule 8 stimulant medicine used to manage ADHD in Australia. It is converted by the body into dexamfetamine after it is taken.
Vyvanse is available for eligible patients following an ADHD assessment. Dosing is individually titrated and monitored by a prescribing doctor, and supply is recorded through real time prescription monitoring.